Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 13, 2025 05:30 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Preclinical Medical Device Testing Services Market to Reach USD 2,842.1 million by 2035, Driven by Regulatory Standards and Technological Advancements | Future Market Insights, Inc.

NEWARK, Del, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The global preclinical medical device testing services market is projected to grow from USD 1,696.0 million in 2025 to USD 2,842.1 million by 2035,...
January 02, 2024 12:33 ET | Source: GlucoTrack, Inc.

GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Rutherford, NJ, Jan. 02, 2024 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device company focused on the design, development, and commercialization...
March 03, 2022 04:49 ET | Source: Vantage Market Research

Global Artificial Intelligence (AI) in Drug Discovery Market ($4197.5 Mn by 2028) Growth Forecast at 41.5% CAGR During 2022 to 2028 COVID Impact and Global Analysis by Vantage Market Research

WASHINGTON, March 03, 2022 (GLOBE NEWSWIRE) -- The Global Artificial Intelligence in Drug Discovery Market size is expected to reach USD 4,197.5 Million by 2028, exhibiting a Compound Annual Growth...
June 22, 2011 11:06 ET | Source: P2D Bioscience

P2D Bioscience Awarded NIH Grant to Develop PD2007

CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Jun 22, 2011) - ...
April 12, 2011 08:00 ET | Source: P2D Bioscience

P2D Bioscience Lead ADHD Drug Demonstrates Efficacy in Preclinical Testing

CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 12, 2011) - P2D Bioscience (P2D, Inc.), a pharmaceutical development company, today announced that its lead Attention Deficit/Hyperactivity Disorder...